Zeng, Donglin; Chen, Qingxia; Chen, Ming-Hui; Ibrahim, Joseph G.; AMGEN research group Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study. (English) Zbl 1437.62669 Biometrika 99, No. 1, 167-184 (2012). Summary: Treatment switching is a frequent occurrence in clinical trials, where, during the course of the trial, patients who fail on the control treatment may change to the experimental treatment. Analysing the data without accounting for switching yields highly biased and inefficient estimates of the treatment effects. We propose a novel class of semiparametric semicompeting risks transition survival models to accommodate treatment switches. Theoretical properties of the proposed model are examined and an efficient expectation-maximization algorithm is derived for obtaining the maximum likelihood estimates. Simulation studies are conducted to demonstrate the superiority of the model compared with the intent-to-treat analysis and other methods proposed in the literature. The proposed method is applied to data from a colorectal cancer clinical trial. Cited in 9 Documents MSC: 62P10 Applications of statistics to biology and medical sciences; meta analysis 92C50 Medical applications (general) 62N02 Estimation in survival analysis and censored data 62G20 Asymptotic properties of nonparametric inference 62-08 Computational methods for problems pertaining to statistics Keywords:expectation-maximization algorithm; maximum likelihood estimate; noncompliance; panitumumab; partial switching; transition model PDFBibTeX XMLCite \textit{D. Zeng} et al., Biometrika 99, No. 1, 167--184 (2012; Zbl 1437.62669) Full Text: DOI Link